Secure to the Max

Federal constraints governing the use and description of drug and biological products add layers of complexity. Intense competition for market share among pharmaceutical manufacturers places a premium on time-to-market and magnifies the pressure on the converter. It is not unusual for converters to work within time frames as narrow as 24 hours between FDA approval and product launch to enable their customers to be “first on the shelf” with a new medication.